NAME: FLORES, JASMINE J.

DATE: DECEMBER 20, 2022

SECTION: 3B-3C CI: PONSO, GOMER

DRUG NAME MECHANISM OF INDICATION/CONTRAI ADVERSE EFFECTS NURSING INTERVENTIONS

ACTION NDICATION

GENERIC NAME: Tramadol is a Indications: CNS: Drowsiness, BEFORE:

centrally acting dizziness, vertigo, Dx:
Tramadol analgesic ● Relief of fatigue, headache,
BRAND NAME: compound. At moderate to somnolence, a. checked the doctor’s order
Ultram least 2 moderately restlessness, b. Noted for any hypersensitivity reaction.
complementary severe pain. euphoria, c. assessed for skin color, texture, lesions, take
CLASSIFICATION mechanisms - Relief of confusion, anxiety, V/S
S: appear moderate to coordination d. reviewed the purpose and importance of the
applicable, disturbance, sleep drug.
Central Nervous severe chronic
binding of disturbances,
System (CNS) pain in adults
parent and M1 seizures. Tx:
Agent, who need
metabolite to a. Prepared the appropriate dosage as
Analgesic, around-the clock CV: Palpitations,
mu-opioid
Narcotic treatment for vasodilation. ordered.
receptors and
(Opiate) Agonist extended periods b. Double checked the medications before
weak inhibition GI: Nausea,
of re- uptake of (ER tablets) going to the patient.
Route: constipation,
norepinephrine ● unlabeled uses: c. Provided comfort to the patient.
vomiting,
IV and serotonin. premature xerostomia,
Subsequently, EDx:
ejaculation; dyspepsia,
Dosage: the release of a. Informed the significant other about the drug’s
restless leg diarrhea,
nociceptive adverse effects.
50 mg PRN syndrome abdominal pain,
neurotransmitter b. Educated the patient about the medication’s
anorexia,
s such as intended use.
Contraindications: flatulence.
substance P,
DURING:
GABA, Contraindicated to Body as a Whole: Dx:
dopamine, patients who has a Sweating, a. Monitored for vital signs.
acetylcholine history of head injury, anaphylactic b. Monitored I&O ratio and pattern.
and epilepsy or other reaction (even with
noradrenaline is seizure disorder, first dose), Tx:
inhibited. The history of drug or withdrawal
a. Evaluated IV site for tenderness and
analgesic alcohol addiction, syndrome (anxiety,
properties of metabolic disorder, sweating, nausea, swelling
Tramadol can using certain tremors, diarrhea, b. Controlled environment (temperature,
be attributed to medicines to treat piloerection, panic lighting, if sweating or CNS effects occur)
norepinephrine migraines, attacks,
and serotonin headaches, muscle paranesthesia,
EDx:
reuptake spasms, depression, hallucinations) with
a. Instructed SO to increase the fluid intake of
blockade in the mental illness, nausea abrupt
CNS, which and vomiting, severe discontinuation. the patient.
inhibits pain asthma or breathing b. Instructed the patient about the
transmission in problems, blockage in Skin: Rash. significance of taking the medication on
the spinal cord. stomach or intestines, Special Senses:
time.
recently used of Visual disturbances.
Source: alcohol, sedatives, AFTER:
Grond S, tranquilizers or Dx:
Sablotzki A: narcotic medications. a. Assessed the patient’s vital signs.
Clinical b. Determined whether the drug is effective.
pharmacology Contraindicated with Tx:
of tramadol. Clin allergy to tramadol or a. Documented drug administration
pharmacokinet . opioids or acute b. Provided safety measures (e.g., adequate
intoxication with lighting, raised side rails, etc.) to prevent
alcohol, opioids or injuries.
psychoactive drugs c. Provided comfort measures
 Edx:
a. Instructed to report if she experiences
severe nausea, dizziness, severe
constipation.
b. Encouraged the patient to verbalize
feelings and concerns.

DRUG NAME MECHANISM OF INDICATION/CONTR ADVERSE EFFECTS NURSING INTERVENTIONS

ACTION AINDICATION

GENERIC NAME: The analgesic INDICATIONS: CNS: dizziness, Before:

KETOROLAC effect of NSAIDs drowsiness, tremors, Dx:
may result from the ● Short term seizures, headaches
BRAND NAME: interference with manageme a. Determined the patient’s name for
KETOROBAS the prostaglandins CV: hypertension, IV. administration
nt of pain
involved in pain. pallors, edema, CV
● Ocular b. Assessed for the level of pain.
CLASSIFICATIONS: Prostaglandins thrombotic events,
itching due c. Checked the dosage and expiration
THERAPEUTIC: appear to sensitize MI, stroke
to seasonal of the drug.
analgesic and pain receptors to
allergic EENT: tinnitus, d. Assess and record vital signs
antipyretic mechanical
conjunctivitis hearing loss, blurred accurately.
stimulation or to
vision
PHARMACOLOGIC other chemical
mediators. NSAIDs CONTRAINDICATIO Tx:
: nonsteroidal anti- GI: nausea,
exert an anti- N:
inflammatory drug anorexia, vomiting, a. Before delivering the medication, do
inflammatory effect diarrhea,
• Hypersensitivity to a comprehensive physical
Route: that may result in
ketorolac and examination to collect baseline
Intravenously part from inhibition
individuals with
 of cyclooxygenase complete or partial constipation, data and analyze any potential side
Dosage: -1 and 0- 2 enzymes syndrome of nasal flatulence, cramps effects.
30 mg/ml every 4 and prostaglandin polyps; b. Placed the patient in a relaxed and
hrs, 4 doses synthesis and angioedema and GU: nephrotoxicity,
comfortable position.
release during bronchospastic dysuria, hematuria,
inflammation. reaction to aspirin oliguria
Edx:
or other NSAIDs; HEMA: blood a. Informed the significant other about
during labor and dyscrasias, the drug’s adverse effects.
delivery; patients prolonged bleeding b. Educated the patient about the
with severe renal medication’s intended use.
SOURCE: impairment or at risk INTEG: purpura, rash, c. Encouraged the patient to verbalize
for renal failure to pruritus, sweating, feelings of tenderness or pain.
Skidmore-Roth, L.
volume depletion; angioedema,
(2020). Mosby’s 2021
patients with risk of stevens-johnson DURING:
Nursing Drug
bleeding; active syndrome, toxic Dx:
Reference Skidmore
peptic ulcer epidermal necrolysis a. Before giving the medication,
Nursing Drug
disease; pre-or double- check the patient’s name.
Reference 34th
intraoperatively; b. Monitored BP frequently.
edition
intrathecal; Tx:
lactation
a.  Check doctor’s order following the
dosage and route accordingly
b. Administer at the right time
scheduled
c. Discontinue if hypersensitivity
reaction occurs

Edx:
 a.  Educate patient and SO about the
purpose and action of the drug
b.  Discuss the possible side effects and
adverse effects
c. Advice SO to inform physician/nurses
for any signs of adverse effects.

AFTER:
Dx:
a. Assessed the patient’s vital signs.
b. Determined whether the drug is
effective.
Tx:
a. Make the patient feel comfortable.
b. Provide safety measures to the
patient.
c. Assess the patient’s needs.

Edx:
a. Encouraged to drink more water and
consume more healthy meals.
b. Encourage significant others to report
any negative reactions or drug
interactions to the nurses.
 DRUG NAME MECHANISM OF INDICATION/CONTR ADVERSE EFFECTS NURSING INTERVENTIONS
ACTION AINDICATION

GENERIC NAME: It suppresses INDICATIONS: CNS: dizziness, Before:

OMEPRAZOLE stomach acid drowsiness, tremors, Dx:
secretion by ● Indicated to seizures, headaches
BRAND NAME: specific inhibition of patients who e. Determined the patient’s name for
the H+/K+-ATPase have gastric CV: pallors, edema,
Prilosec and IV. administration
system found at the and CV thrombotic
Prilosec OTC f. Assessed for the level of pain.
secretory surface of duodenal events, MI, stroke
g. Checked the dosage and expiration
gastric parietal ulcers,
CLASSIFICATIONS: GI: nausea, of the drug.
cells. Because this erosive
THERAPEUTIC: vomiting, diarrhea, h. Assess and record vital signs
enzyme system is
proton-pump esophagitis, constipation, accurately.
regarded as the
inhibitors and
acid (proton, or H+) INTEG: red rashes,
gastroesoph Tx:
pump within the jaundice,
PHARMACOLOGIC ageal reflux
gastric mucosa,
Specific inhibitor c. Before delivering the medication, do
omeprazole inhibits disease
of H+,K(+)-ATPase a comprehensive physical
the final step of (GERD).
or 'proton pump' examination to collect baseline
acid production.
in parietal cells. data and analyze any potential side
CONTRAINDICATIO
effects.
N:
Route: d. Placed the patient in a relaxed and
OREM • Contraindicated comfortable position.
SOURCE: in patients with a
Dosage: history of Edx:
40 milligrams (mg) https://www.mayoclin hypersensitivity to d. Informed the significant other about
ic.org/drugs-supplem the drug or any the drug’s adverse effects.
ents/omeprazole-oral- excipients from the e. Educated the patient about the
route/description/drg- dosage form. medication’s intended use.
20066836 f. Encouraged the patient to verbalize
feelings of tenderness or pain.
DURING:
Dx:
c. Before giving the medication,
double- check the patient’s name.
d. Monitored BP frequently.
Tx:

d.  Check doctor’s order following the

dosage and route accordingly
e. Administer at the right time
scheduled
f. Discontinue if hypersensitivity
reaction occurs

Edx:

d.  Educate patient and SO about the

purpose and action of the drug
e.  Discuss the possible side effects and
adverse effects
f. Advice SO to inform physician/nurses
for any signs of adverse effects.

AFTER:
Dx:
c. Assessed the patient’s vital signs.
d. Determined whether the drug is
effective.
Tx:
 d. Make the patient feel comfortable.
e. Provide safety measures to the
patient.
f. Assess the patient’s needs.

Edx:
c. Encouraged to drink more water and
consume more healthy meals.
d. Encourage significant others to report
any negative reactions or drug
interactions to the nurses.